HEADLINE: Promixin gets smart

[Guest guest]

  Community Pharmacy

                                 April 1, 2003

HEADLINE: Promixin gets smart

    Profile Therapeutics has launched Promixin (colistimethate sodium)

for use

with intelligent inhalers in cystic fibrosis sufferers.

    The drug treats lung infections caused by Pseudomonas aeruginosa, the

most

common cause of chronic respiratory tract infection in patients with CF.

    Promixin is to be used with the new Prodose AAD system which uses

adaptive

aerosol technology (AAD) to deliver drugs to the lungs more efficiently.

The

device is said to constantly analyse the patient's breathing pattern in

order to

deliver a pulse of aerosolised drug into the first half of inhalation,

optimising drug deposition in the lungs.

    Patients prescribed Promixin can have a free Prodose AAD system on an

extended loan basis. The pack contains Prodose Disc, an electronic disc

with

microchip which is inserted into the handpiece before treatment to

control the

dose.

    The NHS price of Promixin is pounds 69 for 30 one million IU vials.

Becki

YOUR FAVORITE LilGooberGirl

YOUNGLUNG EMAIL SUPPORT LIST

www.topica.com/lists/younglung

Pediatric Interstitial Lung Disease Society

http://groups.yahoo.com/group/InterstitialLung_Kids/